- Home
- EDTK vs CLDI Comparison
EDTK vs CLDI Comparison
Compare EDTK & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDTK
- CLDI
- Stock Information
- Founded
- EDTK 2013
- CLDI 2014
- Country
- EDTK China
- CLDI United States
- Employees
- EDTK N/A
- CLDI N/A
- Industry
- EDTK Other Consumer Services
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EDTK Real Estate
- CLDI Health Care
- Exchange
- EDTK Nasdaq
- CLDI Nasdaq
- Market Cap
- EDTK 16.5M
- CLDI 18.1M
- IPO Year
- EDTK 2020
- CLDI N/A
- Fundamental
- Price
- EDTK $1.09
- CLDI $2.11
- Analyst Decision
- EDTK
- CLDI Strong Buy
- Analyst Count
- EDTK 0
- CLDI 3
- Target Price
- EDTK N/A
- CLDI $16.67
- AVG Volume (30 Days)
- EDTK 10.9K
- CLDI 3.1M
- Earning Date
- EDTK 12-31-2024
- CLDI 11-12-2024
- Dividend Yield
- EDTK N/A
- CLDI N/A
- EPS Growth
- EDTK N/A
- CLDI N/A
- EPS
- EDTK N/A
- CLDI N/A
- Revenue
- EDTK $1,999,056.00
- CLDI N/A
- Revenue This Year
- EDTK N/A
- CLDI N/A
- Revenue Next Year
- EDTK N/A
- CLDI N/A
- P/E Ratio
- EDTK N/A
- CLDI N/A
- Revenue Growth
- EDTK N/A
- CLDI N/A
- 52 Week Low
- EDTK $0.77
- CLDI $0.73
- 52 Week High
- EDTK $1.34
- CLDI $26.30
- Technical
- Relative Strength Index (RSI)
- EDTK 59.28
- CLDI 55.08
- Support Level
- EDTK $0.97
- CLDI $1.86
- Resistance Level
- EDTK $1.04
- CLDI $2.30
- Average True Range (ATR)
- EDTK 0.06
- CLDI 0.40
- MACD
- EDTK 0.01
- CLDI -0.04
- Stochastic Oscillator
- EDTK 86.24
- CLDI 12.32
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.